Get an alert when ASPEN PHARMACARE UK LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2027-03-31 (in 10mo)

Last filed for 2025-06-30

Confirmation statement due

2027-01-20 (in 8mo)

Last made up 2026-01-06

Watchouts

None on the register

Cash

Latest balance sheet

Net assets

£15M

-32.4% vs 2024

Employees

Average over period

Profit before tax

£2M

-30.3% vs 2024

Accounts

2-year trend · latest reflected 2025-06-30

Metric Trend 2024-06-302025-06-30
Turnover £29,663,000£29,584,000
Operating profit £2,904,000£1,774,000
Profit before tax £3,268,000£2,278,000
Net profit £2,439,000£1,641,000
Cash £1,115,000
Total assets less current liabilities £22,789,000£15,433,000
Net assets £22,748,000£15,389,000
Equity £22,748,000£15,389,000
Average employees
Wages £1,659,000£1,525,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-06-302025-06-30
Operating margin 9.8%6.0%
Net margin 8.2%5.5%
Return on capital employed 12.7%11.5%
Gearing (liabilities / total assets) 28.8%34.5%
Current ratio 3.25x2.62x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
IFRS
Reporting scope
Standalone (parent only)
Auditor
Ernst & Young
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Company generated a net profit of £1 641 000 (2024: £2 439 000) and has a net asset position of £15 389 000 (2024: £22 748 000). The current assets of the Company exceed its current liabilities by £13 044 000 (2024: £20 620 000). Although the Company had negative cash flows of £1 115 000 for the year ended 30 June 2025 (2024: negative cash flows of £198 000), the Company has the availability of unutilized funding facilities. The directors have also considered the Company's budgets and cash flow forecasts for the period to 31 December 2026. Accordingly, the Directors continue to adopt the going concern basis of accounting in preparing the annual report and financial statements.”

Group structure

  1. ASPEN PHARMACARE UK LIMITED · parent
    1. Aspen Pharma Ireland Limited · Republic of Ireland
    2. Aspen Global Incorporated · Mauritius
    3. Aspen Pharmacare Holdings Limited · South Africa

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

3 active · 3 resigned

Name Role Appointed Born Nationality
FRIGGIERI, Daniel Vella Director 2025-12-31 Jun 1977 Maltese
SCOTT, Nicholas Peter Director 2018-06-12 Nov 1968 British
VAN DER LINDE, Carnie Director 2025-12-31 Mar 1969 South African
Show 3 resigned officers
Name Role Appointed Resigned
BOTHA, Chris Mynhard Director 2020-02-01 2025-12-31
DAVIES, Derek Director 2018-06-12 2020-02-01
DENCHER, Dennis Director 2018-06-12 2019-08-15

Ownership

Persons with significant control

No persons with significant control on record.

Filing timeline

Last 20 of 29 total filings

Date Type Category Description
2026-03-03 AP01 officers Appoint person director company with name date PDF
2026-03-03 AP01 officers Appoint person director company with name date PDF
2026-03-03 TM01 officers Termination director company with name termination date PDF
2026-01-19 CS01 confirmation-statement Confirmation statement with no updates PDF
2026-01-19 CH01 officers Change person director company with change date PDF
2026-01-19 CH01 officers Change person director company with change date PDF
2025-12-03 AA accounts Accounts with accounts type full
2025-01-14 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-11-26 AA accounts Accounts with accounts type full
2024-08-16 CH01 officers Change person director company with change date PDF
2024-08-16 CH01 officers Change person director company with change date PDF
2024-04-15 AA accounts Accounts with accounts type full
2024-01-15 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-07-18 AA accounts Accounts with accounts type full
2023-01-18 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-08-08 AA accounts Accounts with accounts type full
2022-07-01 AD01 address Change registered office address company with date old address new address PDF
2022-01-06 CS01 confirmation-statement Confirmation statement with updates PDF
2021-06-25 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-03-12 AA accounts Accounts with accounts type dormant PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
7

last 12 months

Capital events
0

last 24 months

Officers appointed
2

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2024 → FY2025 · period ending 2025-06-30 vs 2024-06-30

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page